1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Device Benefits
3.3 Segmented Addressable Market
3.4 Trends in the Non-invasive Prenatal Testing Market
3.5 Related Markets
3.5.1 Genetic Testing
3.5.2 Cell-free DNA Testing
3.5.3 Transplantation Diagnostics
3.5.4 Liquid Biopsy
4 Market Outlook
4.1 Market Segmentation
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 Market Characteristics
5.1 DRO – Market Dynamics
5.1.1 Drivers
5.1.1.1 Upsurge in the Number of Babies with Chromosomal Disorders due to Increasing Number of Late Pregnancies
5.1.1.2 Growing Demand for Non-Invasive Procedures for Early Diagnosis
5.1.2 Opportunities
5.1.2.1 Increase in Healthcare Spending and Growing Healthcare Awareness in Emerging Economies
5.1.2.2 Rising Number of Deals Related to the Technology
5.1.3 Restraints
5.1.3.1 High Cost of the Test with Less Reimbursement Facilities
5.1.3.2 Ethical Concerns Related to the Technology
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 Applications: Market Size and Analysis
6.1 Overview
6.2 Trisomy
6.3 Microdeletion Syndrome
6.4 Other NIPT Applications
7 Regions: Market Size and Analysis
7.1 Overview
7.2 North America
7.3 Europe
7.4 Asia Pacific
7.5 Rest of the World
8 Competitive Landscape
8.1 Overview
9 Vendor Profiles
9.1 Natera Inc.
9.1.1 Overview
9.1.2 Geographic Presence
9.1.3 Business Focus
9.1.4 SWOT Analysis
9.1.5 Business Strategies
9.2 Illumina Inc.
9.2.1 Overview
9.2.2 Business Units
9.2.3 Geographic Presence
9.2.4 Business Focus
9.2.5 SWOT Analysis
9.2.6 Business Strategies
9.3 Laboratory Corporation of America Holdings (LabCorp)
9.3.1 Overview
9.3.2 Business Units
9.3.3 Geographic Revenue
9.3.4 Business Focus
9.3.5 SWOT Analysis
9.3.6 Business Strategies
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Overview
9.4.2 Business Units
9.4.3 Geographic Revenue
9.4.4 Business Focus
9.4.5 SWOT Analysis
9.4.6 Business Strategies
9.5 Beijing Genomics Institute
9.5.1 Overview
9.5.2 Business Focus
9.5.3 SWOT Analysis
9.5.4 Business Strategies
10 Companies to Watch For
10.1 Quest Diagnostics
10.1.1 Overview
10.2 LifeCodexx AG
10.2.1 Overview
10.3 Yourgene Health Plc
10.3.1 Overview
10.4 NIPD Genetics
10.4.1 Overview
10.5 Myriad Genetics Inc.
10.5.1 Overview
10.6 PerkinElmer Inc.
10.6.1 Overview
10.7 Next Biosciences (Pty) Limited
10.7.1 Overview
11 Annexure
11.1 Abbreviations